Shanghai Jiaoda Onlly Co., Ltd. operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Jiaoda Onlly Co., Ltd. with three other
companies in this sector in China:
Shanghai Hile Bio-Technology Co Ltd
sales of 303.65 million Chinese Renmimbi [US$43.65 million]
of which 100%
was Animal Vaccine),
Jiangsu Sihuan Bioengineering Co., Ltd.
(345.94 million Chinese Renmimbi [US$49.73 million]
of which 94%
was Medicine), and
Zhejiang Wolwo Bio Pharmaceutical Co Ltd
(385.58 million Chinese Renmimbi [US$55.43 million]
of which 99%
was Pharmaceutical Manufacturing).
During the year ended December of 2017, sales at
Shanghai Jiaoda Onlly Co., Ltd. were 282.07 million Chinese Renmimbi (US$40.55 million).
increase of 5.2%
versus 2016, when the company's sales were 268.22 million Chinese Renmimbi.
Sales of Real Estate saw an increase
that was more than double the company's growth rate: sales were up
65.1% in 2017, from
8.93 million Chinese Renmimbi to 14.74 million Chinese Renmimbi.
Shanghai Jiaoda Onlly Co., Ltd. also saw significant increases in sales in
Industry (up 12.4% to 141.88 million Chinese Renmimbi)
Not all segments of Shanghai Jiaoda Onlly Co., Ltd. experienced an increase in sales in 2017:
sales of Other Operations fell 30.3% to 2.58 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).